SEQUENT SCIENTIFIC
Back to Balance Sheet
|
SEQUENT SCIENTIFIC Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹263 Cr | ₹173 Cr | ₹176 Cr | ₹209 Cr | ₹154 Cr |
What is the latest Total Non-Current Liabilities ratio of SEQUENT SCIENTIFIC ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹263 Cr |
| Mar2024 | ₹173 Cr |
| Mar2023 | ₹176 Cr |
| Mar2022 | ₹209 Cr |
| Mar2021 | ₹154 Cr |
How is Total Non-Current Liabilities of SEQUENT SCIENTIFIC Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹263 Cr | 52.53 | |
| Mar2024 | ₹173 Cr | -1.85 | |
| Mar2023 | ₹176 Cr | -15.92 | |
| Mar2022 | ₹209 Cr | 36.16 | |
| Mar2021 | ₹154 Cr | - | |
Compare Total Non-Current Liabilities of peers of SEQUENT SCIENTIFIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SEQUENT SCIENTIFIC | ₹8,742.4 Cr | -8.8% | -0.6% | 36.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
SEQUENT SCIENTIFIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SEQUENT SCIENTIFIC | -8.8% |
-0.6% |
36.8% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses